DOD Peer Reviewed Cancer, Clinical Trial Award

The Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) for fiscal year 2025 aims to support clinical trials that demonstrate significant potential in cancer treatment, specifically addressing designated topic areas relevant to military health. Applications are accepted from both domestic and international organizations, provided that principal investigators hold appropriate qualifications. Key details include: - Submission timelines: Pre-applications are due by June 20, 2025, with full applications by September 25, 2025. - Funding Limit: Projects are capped at total costs of $4.2 million over a maximum performance period of four years. - Required studies range from initial proof-of-concept trials to phase III trials, with preclinical data required to support applications. No animal studies are permitted. - Research must address one or more specified cancer types, emphasizing relevance to military populations and their health concerns. - The application process is two-step: an initial pre-application followed by a full application for invited candidates, with specific criteria for content and formatting. This funding opportunity underscores the DOD's commitment to advancing cancer research that meets the needs of service members, veterans, and their families.